Aggregator

Khaliqur Rahman,
Kanishka Chaurasia,
Kartik Jain,
Kusum Gupta,
Mona Vijayaran,
Manoj Kumar Sarkar,
Manish K. Singh,
Dinesh Chandra,
Ruchi Gupta,
Yadav Sanjeev,
Rajesh Kashyap

Tissue factor‐positive platelets in clinical flow cytometry: From functional heterogeneity to cardiovascular risk stratification

Cytometry Part B: Clinical Cytometry

1 week 4 days ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Marina Camera

Improved sample stability for clinical whole blood receptor occupancy assays with cryopreservation

Cytometry Part B: Clinical Cytometry

1 week 4 days ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Chunli Huang,
Wen‐I Tsou,
Pu Fang,
Katharine D. Grugan

ESCCA recommendations for managing measurement uncertainty in ISO 15189 accredited flow cytometry laboratories: A risk‐based approach

Cytometry Part B: Clinical Cytometry

3 weeks ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Ulrika Johansson,
Catarina Martins,
Neil McIver‐Brown,
Eleni Linskens,
Efthalia Yiannaki,
Thomas Keller,
David Bloxham,
Francesco Buccisano,
Kathryn Clarke,
Maria João Acosta,
Katy Jones,
Wolfgang Kern,
Juan Flores‐Montero,
Daniel Payne, …

CYTO 2026—Concluding Thoughts on the Next Wave of Cytometry From the Conference Chairs

Cytometry Part A

3 weeks 2 days ago

Cytometry Part A, EarlyView.

Silas Leavesley,
Jingjing Zhao

High‐Dimensional Spectral Flow Cytometry Panel for Immunophenotypic Characterization of Fixed Whole Blood Samples

Cytometry Part A

4 weeks ago

Cytometry Part A, EarlyView.

Vaishnavi Parthasarathy,
Alexander T. Heubeck,
Tyanna Stuckey,
Veronica Hernandez,
Blessing Musgrove,
Maia M. Bennett‐Boehm,
Troy Torgerson,
Peter Skene,
Julian Reading

A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE‐GLM) for Longitudinal Flow Cytometry Maturation Data Analysis

Cytometry Part A

4 weeks 1 day ago

Cytometry Part A, EarlyView.

Sixuan Joanna Wang,
Ruben Deneer,
Tom Schoenmakers,
Stefan G. C. Mestrum,
Yvonne M. C. Henskens,
Otto Bekers,
Anton H. N. Hopman,
Frans C. S. Ramaekers,
Mathie P. G. Leers

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma—Experience in real‐world practice

Cytometry Part B: Clinical Cytometry

4 weeks 2 days ago

Cytometry Part B: Clinical Cytometry, EarlyView.

K. Balaji,
Sitaram G. Ghogale,
Nilesh Deshpande,
Jagruti Patil,
Karishma Girase,
Suresh Poojary,
Gaurav Chatterjee,
Sweta Rajpal,
Nikhil Patkar,
Sridhar Epari,
Tanuja Shet,
Sumeet Gujral,
P. G. Subramanian,
Prashant R. Tembhare

Correction to “Issue highlights—July 2026”

Cytometry Part B: Clinical Cytometry

1 month ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Cytoflow: User‐Friendly Python Software for Computational Flow Cytometry

Cytometry Part A

1 month ago

Cytometry Part A, EarlyView.

Leah Teague

Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia

Cytometry Part B: Clinical Cytometry

1 month 1 week ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Ju‐Hyeong Lee,
Tae‐Shin Kim,
Sang Mee Hwang,
Hyungsuk Kim,
Yoon Hwan Chang,
Hyun Kyung Kim,
Seon Young Kim

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort

Cytometry Part B: Clinical Cytometry

1 month 1 week ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Carlos Agustin Villegas Valverde,
Yendry Ventura Carmenate,
Vianed Marsan Suarez,
Yandy Marx Castillo Aleman,
Imilla Casado Hernandez,
Rachely Hernandez Corrales

Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3‐negative T cell neoplasms

Cytometry Part B: Clinical Cytometry

1 month 1 week ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Aaron J. Wilk,
Gary Gitana,
Jean Oak

Platelet flow cytometry: An evolving platform for clinical hematology

Cytometry Part B: Clinical Cytometry

1 month 2 weeks ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Benjamin E. J. Spurgeon

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B‐cell acute lymphoblastic leukemia: A report from The Cytometry Society, India

Cytometry Part B: Clinical Cytometry

1 month 2 weeks ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Prashant Tembhare,
Kunal Sehgal,
Karthik Bommannan,
Khaliqur Rahman,
Sachin Jain,
Nitin Dayal,
Sitaram Ghogale,
Ananthvikas Jayaram,
Man Updesh Singh Sachdeva,
Ritu Gupta,
Papagudi G. Subramanian,
Prabhu Manivannan,
Mohan Galande,
Manasi…

CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL

Cytometry Part B: Clinical Cytometry

1 month 2 weeks ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Man Chen,
Jing Zhou,
Wei Zhao,
Jing Long,
Minjing Fu,
Xian Zhang,
Yi Li,
Gailing Zhang,
Hui Wang

Automated B‐cell and plasma cell identification using unsupervised clustering by FlowSOM and an excel‐based classification model

Cytometry Part B: Clinical Cytometry

1 month 2 weeks ago

Cytometry Part B: Clinical Cytometry, EarlyView.

Ethan James Gantana,
Ernest Musekwa,
Erica‐Mari Nell,
Zivanai Cuthbert Chapanduka

	NIH Electronic Directory
	NSF Award Search
	PubMed Central
	NIH Reporter

Purdue University Cytometry Laboratories

> Purdue Cytometry Discussion List

> Obituaries

Twitter

What is the optimal threshold for aberrant lymphoblasts at diagnosis to predict lymphoid transformation in chronic myeloid leukemia?

Velociraptor Machine Learning Quantifies Similarity to Known Cell Types and Matches Cells Across Flow and Imaging Cytometry Platforms

Coexistence of immunophenotypically normal and aberrant mast cells in patients with clonal mast cell diseases associates with more indolent subtypes and less severe disease characteristics

CD71‐based immature RBC (iRBC) analysis in peripheral blood has a better correlation with leukocyte PNH clone size and improves the delineation of different PNH clone types

Tissue factor‐positive platelets in clinical flow cytometry: From functional heterogeneity to cardiovascular risk stratification

Improved sample stability for clinical whole blood receptor occupancy assays with cryopreservation

ESCCA recommendations for managing measurement uncertainty in ISO 15189 accredited flow cytometry laboratories: A risk‐based approach

CYTO 2026—Concluding Thoughts on the Next Wave of Cytometry From the Conference Chairs

High‐Dimensional Spectral Flow Cytometry Panel for Immunophenotypic Characterization of Fixed Whole Blood Samples

A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE‐GLM) for Longitudinal Flow Cytometry Maturation Data Analysis

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma—Experience in real‐world practice

Correction to “Issue highlights—July 2026”

Cytoflow: User‐Friendly Python Software for Computational Flow Cytometry

Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort

Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3‐negative T cell neoplasms

Platelet flow cytometry: An evolving platform for clinical hematology

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B‐cell acute lymphoblastic leukemia: A report from The Cytometry Society, India

CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL

Automated B‐cell and plasma cell identification using unsupervised clustering by FlowSOM and an excel‐based classification model

Searches